Page last updated: 2024-08-16

ribavirin and Thrombocytopenia

ribavirin has been researched along with Thrombocytopenia in 93 studies

Research

Studies (93)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (2.15)	18.7374
1990's	3 (3.23)	18.2507
2000's	29 (31.18)	29.6817
2010's	57 (61.29)	24.3611
2020's	2 (2.15)	2.80

Authors

Authors	Studies
Egawa, K; Fujii, H; Fukushi, S; Furuta, Y; Harada, S; Komeno, T; Kurosu, T; Lim, CK; Maeki, T; Morikawa, S; Nakajima, N; Saijo, M; Shimojima, M; Takayama-Ito, M; Tani, H; Taniguchi, S; Uda, A; Yamada, S; Yoshikawa, T	1
Huang, C; Li, J; Li, L; Li, X; Sun, S; Xia, G; Zhang, Z; Zhou, S; Zou, G	1
Arima, N; Baba, M; Okamoto, M; Saijo, M; Sakakibara, N; Toyama, M	1
Iqbal, S; Raza, A; Yousaf, MI; Yousuf, MH	1
Fazylov, VC; Guryanova, SV; Manapova, ER	1
Maltezos, E; Maltezou, HC; Markatou, F; Papa, A; Papadopoulou, E; Pervanidou, D; Terzi, E; Tsiodras, S; Ventouri, S	1
Abbas, SM; El-Feky, HM; Hegab, MF; Lashin, AH; Metwally, MA; Shaheen, YA	1
Alavi-Naini, R; Amjadi, A; Metanat, M; Mohammadi, M; Shakeri, A; Sharifi-Mood, B	1
Aizawa, N; Enomoto, H; Iijima, H; Ikeda, N; Imanishi, H; Iwata, K; Iwata, Y; Nishiguchi, S; Saito, M; Sakai, Y; Takashima, T; Tanaka, H	1
Afdhal, NH; Bakulin, I; Brainsky, A; Campbell, FM; Chen, PJ; Dusheiko, GM; Geib, J; Giannini, EG; Han, KH; Kamel, YM; Lawitz, E; Mohsin, A; Patwardhan, R; Poordad, F; Rodriguez-Torres, M; Rugina, S; Shiffman, ML; Tayyab, GU; Theodore, D; Vasey, SY	1
Backus, LI; Belperio, PS; Cheung, R; Mole, LA; Shahoumian, TA	1
Chen, CY; Chien, RN; Fang, CC; Fang, YJ; Hsu, CW; Huang, YH; Hung, CH; Lee, CM; Lu, SN; Peng, CY; Tsai, TJ; Tseng, KC; Tung, SY; Yeh, CT	1
Furusyo, N; Hayashi, J; Hayashi, T; Ihara, T; Ikezaki, H; Kainuma, M; Kajiwara, E; Murata, M; Ogawa, E; Okada, K; Satoh, T; Takahashi, K; Toyoda, K	1
Buccoliero, G; Massa, P; Pisconti, S; Resta, F; Urbano, T	1
Hidaka, H; Jiang, W; Kitagawa, H; Koizumi, W; Nakazawa, T	1
Andriulli, A; Cozzolongo, R; Fontana, R; Iacobellis, A; Ippolito, A; Minerva, N; Niro, GA; Palmieri, O; Valvano, MR	1
Altincatal, A; Cho, K; Gagnon, DR; Grotzinger, KM; Hermos, JA; Lawler, EV; Quach, L; Weber, HC	1
Akahoshi, T; Azuma, K; Dohmen, K; Furusyo, N; Hayashi, J; Kajiwara, E; Kawano, A; Kotoh, K; Maehara, Y; Nakamuta, M; Nomura, H; Ogawa, E; Satoh, T; Shimoda, S; Takahashi, K; Tanabe, Y	1
Gomersall, CD; Leung, CH	1
Angeli, E; Caputo, A; Cattelan, AM; Iannacone, C; Maida, I; Nasta, P; Pontali, E; Puoti, M; Verucchi, G	1
Cheng, HS; Hung, CH; Hung, IW; Hwang, JJ; Lin, CH; Lo, CC; Tsai, WJ	1
Abe, H; Aizawa, Y; Atsukawa, M; Fukuda, T; Itokawa, N; Iwakiri, K; Kawamoto, C; Kondo, C; Matsushita, Y; Nakagawa, A; Nakatsuka, K; Sakamoto, C; Shimada, N; Tsubota, A	1
Joshita, S; Tanaka, E	1
Afdhal, NH; Campbell, FM; Dusheiko, GM; Elkashab, M; Giannini, EG; Iyengar, M; Muir, AJ; Reddy, KR; Romero-Gómez, M; Sigal, SH; Theodore, D; Vasey, SY; Vijayaraghavan, S	1
Deguchi, H; Ichinose, M; Iguchi, M; Inoue, I; Kato, J; Maeda, Y; Maekita, T; Mori, Y; Moribata, K; Muraki, Y; Nuta, J; Shimizu, R; Shingaki, N; Takifuji, K; Tamai, H; Yamaue, H	1
Demuth, D; Forssen, U; Grotzinger, K; Irving, WL; Rizzetto, M; Roughley, A; Theodore, D	1
Collado, A; de los Santos-Gil, I; Girón-González, JA; López-Cortés, LF; Macías, J; Merino, D; Mira, JA; Neukam, K; Ojeda-Burgos, G; Pérez-Pérez, M; Pineda, JA; Ríos-Villegas, MJ; Rivero, A; Rivero-Juárez, A; Téllez, F; Torres-Cornejo, A	1
Almasio, PL; Boccaccio, V; Bruno, S; Giannini, EG; Russo, ML; Sewpaul, P	1
Berenguer, M; Everson, G; Ferenci, P; Forns, X; Fried, MW; Lopez-Talavera, JC; Lovell, S; Pedrosa, M; Poordad, F; Shiffman, ML; Trinh, R; Wedemeyer, H	1
Mikadze, I; Vashakidze, E	1
Chi, X; Gao, X; Jiang, J; Kong, F; Lv, J; Mei, R; Niu, J; Pan, Y; Sun, B; Sun, H; Wang, X; Wu, R; Xu, H; Yu, G; Zhong, J	1
Kishk, R; Mandour, M; Nemr, N	1
Camacho, A; Cuenca, F; Frias, M; Gonzalez, R; Gordon, A; Manzanares-Martín, B; Peña, J; Perez-Camacho, I; Pineda, JA; Rivero, A; Rivero-Juarez, A; Rodriguez-Cano, D	1
Diago, M; Peño, L; Plana, L; Urquijo, JJ	1
Choe, PG; Choi, SJ; Kim, KH; Kim, NJ; Lee, MJ; Oh, MD; Park, WB; Yi, J	1
Kim, CJ; Song, TY; Yang, EM	1
Kiciak, SG; Krzowska-Firych, J; Modrzewska, R	1
Kristian, P; Pellová, A; Porubcin, S; Schréter, I	1
Godeau, B	1
McHutchison, JG; Patel, K; Tillmann, HL	1
Ferenci, P	1
Alba, LM; Bulchandani, D; Nachnani, JS; Pandya, PK; Rao, GA	1
Aketa, H; Chiba, M; Ikezawa, K; Iwahashi, K; Kanno, T; Katayama, K; Kita, H; Maeda, K; Matsuura, T; Michida, T; Mizuno, T; Naito, M; Nishio, A; Onishi, Y; Ono, A; Yumiba, T	1
Chow, DC; Khawcharoenporn, T; Suwantarat, N; Tice, AD	1
Mac Nicholas, R; Norris, S	1
Fujishiro, T; Kato, H; Narita, M	1
Bakulin, IG; Iakovleva, EV; Moliarenko, EV; Sharabanov, AS	1
Hama, T; Hayami, S; Ichinose, M; Shigekawa, Y; Takifuji, K; Tamai, H; Uchiyama, K; Ueno, M; Yamaue, H	1
Grotzinger, K; Poordad, F; Sullivan, J; Theodore, D	1
Beinhardt, S; Ferenci, P; Ferlitsch, A; Gangl, A; Hofer, H; Kundi, M; Payer, BA; Peck-Radosavljevic, M; Reiberger, T; Rutter, K; Trauner, M	1
Arai, H; Hirokawa, T; Horiuchi, K; Kakizaki, S; Mori, M; Naganuma, A; Ohyama, T; Sato, K; Shimada, Y; Tahara, H; Takagi, H; Tojima, H	1
Enomoto, N; Hiasa, Y; Hige, S; Hino, K; Honda, M; Itoh, Y; Izumi, N; Kaneko, S; Koike, A; Kurosaki, M; Matsuura, K; Mizokami, M; Mochida, S; Nishida, N; Nishiguchi, S; Sakamoto, N; Sugauchi, F; Sugiyama, M; Tanaka, E; Tanaka, Y; Tokunaga, K; Yatsuhashi, H	1
Afdhal, NH; Albrecht, JK; Brass, CA; Clark, PJ; Esteban, R; Fellay, J; Galler, GW; Ge, D; Goldstein, DB; Jacobson, IM; King, JW; Kwo, PY; Lawitz, EJ; McCone, J; McHutchison, JG; Muir, AJ; Naggie, S; Noviello, S; Patel, K; Pedicone, LD; Poordad, F; Shianna, KV; Shiffman, ML; Singh, A; Sulkowski, MS; Thompson, AJ; Tillmann, HL; Urban, TJ; Zhu, M; Zhu, Q	1
Dróżdż, W; Dybowska, D; Halota, W; Kozielewicz, D	1
Akahoshi, T; Furusyo, N; Hashizume, M; Hayashi, J; Kawanaka, H; Kinjo, N; Maehara, Y; Nagao, Y; Tomikawa, M; Tsutsumi, N	1
Alric, L; Beynes-Rauzy, O; Bonnet, D; Izopet, J; Kamar, N	1
Ando, M; Hirohata, M; Imagawa, A; Miyake, Y; Miyatake, H; Nakatsu, M; Takahara, M; Yamamoto, K	1
Battyáni, Z; Hunyady, B; Kovács, B	1
Chan, HH; Chen, WC; Hsu, PI; Lai, KH; Lin, CK; Lin, KH; Tsai, WL; Yu, HC	1
Fazio, V; Giannini, EG; Marenco, S; Picciotto, A; Pieri, G; Savarino, V	1
Berak, H; Dusheiko, GM; Ferenci, P; Gane, EJ; Hadziyannis, SJ; Han, KH; Harley, HA; Horsmans, YJ; Husa, P; Jenny Heathcote, E; Lee, SS; Messinger, D; Roberts, SK; Tatsch, F	1
Naveau, S; Perlemuter, G; Voican, CS	1
Chen, CH; Hung, CH; Kee, KM; Lee, CM; Lu, SN; Wang, JH	1
Egle, A; Greil, R; Grundbichler, M; Melchardt, T; Strasser, M; Taylor, N	1
Cacoub, P	1
Gournay, J; Richou, C	1
Afdhal, NH	1
Ong, JP; Younossi, ZM	1
Collantes, R; Gujral, H; Viscomi, C	1
Kowdley, KV	1
Collantes, RS; Younossi, ZM	1
Afdhal, NH; Curry, MP	1
Sulkowski, MS	1
Bárcena, R; Blázquez, J; Foruny, JR; Gil-Grande, L; Moreno, A; Moreno, J; Moreno, S; Muriel, A; Pérez-Elías, MJ; Quereda, C; Rodriguez-Sagrado, MA; Sánchez, J	1
Kakizaki, S; Mori, M; Sato, K; Sohara, N; Takagi, H	1
Becker, MC; Bresson-Hadni, S; Bronowicki, JP; Di Martino, V; Lunel-Fabiani, F; Miguet, JP; Thevenot, T; Vanlemmens, C	1
Elefsiniotis, IS; Fotos, NV; Mavrogiannis, C; Moulakakis, A; Pantazis, KD	1
Arase, Y	1
Deschênes, M; Hilzenrat, N; Nudo, CG; Wong, P	1
Ferenci, P; Formann, E; Gangl, A; Homoncik, M; Jilma, B; Peck-Radosavljevic, M; Schmid, M; Sieghart, W	1
Alves Couto, C; Costa Faria, L; de Abreu Ferrari, TC; de Melo Couto, OF; de Paula Farah, K; Dias Ribeiro, D	1
Bergholz, U; Ferenci, P; Gurguta, C; Hofer, H; Steindl-Munda, P	1
Arora, S; Gish, RG; Murphy, B; Nelson, DR; O'Brien, C; Rajender Reddy, K; Xu, Y	1
Halász, T; Horváth, G; Stotz, G; Tolvaj, G	1
Esposito, S; Hamzeh, FM; Rustgi, VK; Shiffman, ML	1
Bonkovsky, HL; Dienstag, JL; Everson, GT; Ghany, MG; Lee, WM; Lindsay, KL; Lok, AS; Morgan, TR; Morishima, C; Shiffman, ML; Wright, EC	1
Arizcorreta-Yarza, A; Collado, A; Fernández-Fuertes, E; Girón-González, JA; González-Serrano, M; López-Cortés, LF; Lozano, F; Macías, J; Merino, D; Mira, JA; Pineda, JA; Ríos-Villegas, MJ; Rivero, A; Torres-Tortoso, M; Valera-Bestard, B	1
Blanche, P; Bouscary, D	1
Carmona, I; Herrerías-Esteban, JM; Herrerías-Gutiérrez, JM; Jiménez-Sáenz, M; Piñar, A; Rebollo, J; Rojas, M; Salas, E	1
Povey, RC	1
Craven, RB; Fisher-Hoch, S; McCormick, JB; Sasso, D	1

Reviews

15 review(s) available for ribavirin and Thrombocytopenia

Article	Year
[Thrombocytopenia in HCV infection. Natural interferon as an alternative therapy]. Przeglad epidemiologiczny, 2007, Volume: 61, Issue:4 Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Ribavirin; Thrombocytopenia	2007
Peginterferon and ribavirin in HCV: improvement of sustained viral response. Best practice & research. Clinical gastroenterology, 2008, Volume: 22, Issue:6 Topics: Anemia; Antiviral Agents; Clinical Trials as Topic; Depression; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Medication Adherence; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Thrombocytopenia; Treatment Outcome	2008
Review article: optimizing SVR and management of the haematological side effects of peginterferon/ribavirin antiviral therapy for HCV - the role of epoetin, G-CSF and novel agents. Alimentary pharmacology & therapeutics, 2010, Volume: 31, Issue:9 Topics: Anemia; Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia; Viral Load	2010
[Thrombocytopenia in patients with chronic hepatitis C]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2010, Issue:5 Topics: Antiviral Agents; Biomarkers; Disease Progression; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia	2010
[Side-effects of pegylated interferon plus ribavirin therapy with or without protease inhibitor direct acting antiviral agents during treatment of chronic hepatitis C virus infection]. Orvosi hetilap, 2011, Dec-11, Volume: 152, Issue:50 Topics: Affect; Anemia, Hypochromic; Antiviral Agents; Autoimmune Diseases; Autoimmunity; Cardiovascular System; Clinical Trials as Topic; Drug Eruptions; Drug Synergism; Drug Therapy, Combination; Endocrine System Diseases; Eye; Hepatitis C, Chronic; Humans; Infections; Interferon alpha-2; Interferon-alpha; Neutropenia; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Recombinant Proteins; Respiratory System; Ribavirin; Risk Factors; Thrombocytopenia	2011
[Treatment of extrahepatic manifestations associated with hepatitis C virus infection]. Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2 Topics: Antiviral Agents; Autoantibodies; Cryoglobulinemia; Drug Therapy, Combination; Fatigue; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C; Hepatitis C, Chronic; Humans; Interferons; Lymphoproliferative Disorders; Male; Middle Aged; Odds Ratio; Porphyria Cutanea Tarda; Pruritus; Ribavirin; Sjogren's Syndrome; Surveys and Questionnaires; Thrombocytopenia; Time Factors; Vascular Diseases	2002
[Treatment of chronic hepatitis C: side effects, tolerability and quality of life]. Gastroenterologie clinique et biologique, 2002, Volume: 26 Spec No 2 Topics: Anemia, Hemolytic; Antiviral Agents; Blood Cell Count; Clinical Trials as Topic; Controlled Clinical Trials as Topic; Depressive Disorder; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon-alpha; Kidney Transplantation; Liver Transplantation; Mental Disorders; Neutropenia; Prospective Studies; Quality of Life; Retrospective Studies; Ribavirin; Risk Factors; Thrombocytopenia; Time Factors	2002
Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopenia. Cleveland Clinic journal of medicine, 2004, Volume: 71 Suppl 3 Topics: Anemia; Antiviral Agents; Clinical Trials as Topic; Darbepoetin alfa; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Filgrastim; Granulocyte Colony-Stimulating Factor; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukin-11; Neutropenia; Patient Compliance; Polyethylene Glycols; Quality of Life; Randomized Controlled Trials as Topic; Recombinant Proteins; Ribavirin; Thrombocytopenia	2004
The role of physician extenders in managing patients with chronic hepatitis C. Cleveland Clinic journal of medicine, 2004, Volume: 71 Suppl 3 Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Neutropenia; Nurse Practitioners; Patient Compliance; Patient Education as Topic; Physician Assistants; Quality of Health Care; Ribavirin; Risk Factors; Social Support; Thrombocytopenia	2004
Hematologic side effects of interferon and ribavirin therapy. Journal of clinical gastroenterology, 2005, Volume: 39, Issue:1 Suppl Topics: Anemia, Hypochromic; Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; Erythropoietin; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia	2005
The use of growth factors to manage the hematologic side effects of PEG-interferon alfa and ribavirin. Journal of clinical gastroenterology, 2005, Volume: 39, Issue:1 Suppl Topics: Anemia, Hypochromic; Antiviral Agents; Darbepoetin alfa; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Granulocyte Colony-Stimulating Factor; Growth Substances; Hematinics; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia	2005
Use of growth factors with antiviral therapy for chronic hepatitis C. Clinics in liver disease, 2005, Volume: 9, Issue:3 Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon Type I; Neutropenia; Patient Compliance; Quality of Life; Recombinant Proteins; Ribavirin; Thrombocytopenia	2005
Management of the hematologic complications of hepatitis C therapy. Clinics in liver disease, 2005, Volume: 9, Issue:4 Topics: Anemia; Antiviral Agents; Bone Marrow; Epoetin Alfa; Erythropoietin; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon Type I; Neutropenia; Recombinant Proteins; Ribavirin; Thrombocytopenia	2005
[Complementary treatments of chronic viral hepatitis C]. Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:2 Topics: Anemia; Antidepressive Agents; Antioxidants; Antiviral Agents; Erythropoietin; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia	2006
[Side effects of interferon therapy for chronic hepatitis C]. Nihon rinsho. Japanese journal of clinical medicine, 2006, Volume: 64, Issue:7 Topics: Antiviral Agents; Drug Therapy, Combination; Fatigue; Hepatitis C, Chronic; Humans; Interferons; Leukopenia; Mental Disorders; Ribavirin; Thrombocytopenia	2006

Trials

15 trial(s) available for ribavirin and Thrombocytopenia

Article	Year
Sofosbuvir Adverse Events Profile in a Subset of Pakistani Population. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:2 Topics: Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Neutropenia; Pancytopenia; Ribavirin; Sofosbuvir; Thrombocytopenia; Treatment Outcome	2018
Efficacy of high-dose methylprednisolone in patients with Crimean-Congo haemorrhagic fever and severe thrombocytopenia. Tropical doctor, 2013, Volume: 43, Issue:2 Topics: Administration, Oral; Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Glucocorticoids; Hemorrhagic Fever, Crimean; Humans; Male; Methylprednisolone; Middle Aged; Ribavirin; Thrombocytopenia; Young Adult	2013
Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C. Journal of gastroenterology, 2014, Volume: 49, Issue:8 Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Embolization, Therapeutic; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prognosis; Recombinant Proteins; Ribavirin; Spleen; Splenectomy; Thrombocytopenia; Treatment Outcome	2014
Eltrombopag increases platelet numbers in thrombocytopenic patients with HCV infection and cirrhosis, allowing for effective antiviral therapy. Gastroenterology, 2014, Volume: 146, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Benzoates; Drug Administration Schedule; Female; Follow-Up Studies; Hematologic Agents; Hepatitis C, Chronic; Humans; Hydrazines; Induction Chemotherapy; Intention to Treat Analysis; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Maintenance Chemotherapy; Male; Middle Aged; Platelet Count; Polyethylene Glycols; Pyrazoles; Recombinant Proteins; Ribavirin; Thrombocytopenia; Treatment Outcome; Young Adult	2014
A double-blind randomized controlled study to evaluate the efficacy of low-dose oral interferon-alpha in preventing hepatitis C relapse. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research, 2014, Volume: 34, Issue:3 Topics: Antiviral Agents; Double-Blind Method; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Secondary Prevention; Thrombocytopenia; Treatment Outcome	2014
Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosis. Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:9 Topics: Adult; Aged; Alleles; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Liver Cirrhosis; Male; Middle Aged; Oligopeptides; Platelet Count; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Severity of Illness Index; Splenectomy; Thrombocytopenia; Treatment Outcome; Young Adult	2014
Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study. Antiviral therapy, 2015, Volume: 20, Issue:1 Topics: Adult; Anemia; Antiviral Agents; Cell Count; Coinfection; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia; Viral Load	2015
12 weeks of interferon-based therapy is feasible in patients with hepatitis C-related cirrhosis and thrombocytopenia: A post hoc analysis of eltrombopag studies. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2015, Volume: 47, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Albumins; Antiviral Agents; Benzoates; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Hydrazines; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Pyrazoles; Ribavirin; Risk Factors; Severity of Illness Index; Thrombocytopenia; Treatment Outcome	2015
Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemia. Liver international : official journal of the International Association for the Study of the Liver, 2015, Volume: 35, Issue:11 Topics: 2-Naphthylamine; Adolescent; Adult; Aged; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Hypertension, Portal; Hypoalbuminemia; Lactams, Macrocyclic; Liver Cirrhosis; Macrocyclic Compounds; Male; Middle Aged; Proline; Ribavirin; Sulfonamides; Thrombocytopenia; Treatment Outcome; Uracil; Valine; Young Adult	2015
Safety of peginterferon alfa-2a plus ribavirin in a large multinational cohort of chronic hepatitis C patients. Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:8 Topics: Adult; Anemia; Antiviral Agents; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon-alpha; Internationality; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Factors; Thrombocytopenia; Treatment Outcome	2012
Improvement of thrombocytopenia in hepatitis C-related advanced fibrosis patients after sustained virological response. Digestive diseases and sciences, 2013, Volume: 58, Issue:2 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Recombinant Proteins; Ribavirin; Severity of Illness Index; Thrombocytopenia; Time; Treatment Outcome	2013
Erythropoietin treatment is associated with more severe thrombocytopenia in patients with chronic hepatitis C undergoing antiviral therapy. The American journal of gastroenterology, 2006, Volume: 101, Issue:10 Topics: Adult; Antiviral Agents; Blood Cell Count; Double-Blind Method; Drug Therapy, Combination; Erythropoietin; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; P-Selectin; Polyethylene Glycols; Receptor, PAR-1; Recombinant Proteins; Ribavirin; Thrombocytopenia	2006
Virological response and safety outcomes in therapy-nai ve patients treated for chronic hepatitis C with taribavirin or ribavirin in combination with pegylated interferon alfa-2a: a randomized, phase 2 study. Journal of hepatology, 2007, Volume: 47, Issue:1 Topics: Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Thrombocytopenia; Treatment Outcome	2007
[The role and possibilities of natural interferon treatment in chronic hepatitis C: experience with natural interferon treatment for patients barred from combined antiviral therapy because of the STOP rule]. Orvosi hetilap, 2007, Aug-19, Volume: 148, Issue:33 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Hungary; Interferon alpha-2; Interferon-alpha; Interferons; Leukopenia; Male; Middle Aged; Polyethylene Glycols; Practice Guidelines as Topic; Recombinant Proteins; Ribavirin; Thrombocytopenia; Treatment Outcome; Viral Load	2007
Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin. Alimentary pharmacology & therapeutics, 2008, Mar-01, Volume: 27, Issue:5 Topics: Adult; Anemia; Antiviral Agents; Depression; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Multicenter Studies as Topic; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Surveys and Questionnaires; Thrombocytopenia; Time Factors; Viral Load	2008

Other Studies

63 other study(ies) available for ribavirin and Thrombocytopenia

Article	Year
Susceptibility of Type I Interferon Receptor Knock-Out Mice to Heartland Bandavirus (HRTV) Infection and Efficacy of Favipiravir and Ribavirin in the Treatment of the Mice Infected with HRTV. Viruses, 2022, 07-28, Volume: 14, Issue:8 Topics: Amides; Animals; Disease Models, Animal; Humans; Mice; Mice, Knockout; Phlebovirus; Pyrazines; Receptor, Interferon alpha-beta; Ribavirin; Solvents; Thrombocytopenia	2022
A new model for predicting the outcome and effectiveness of drug therapy in patients with severe fever with thrombocytopenia syndrome: A multicenter Chinese study. PLoS neglected tropical diseases, 2023, Volume: 17, Issue:3 Topics: C-Reactive Protein; Humans; Phlebovirus; Retrospective Studies; Ribavirin; Severe Fever with Thrombocytopenia Syndrome; Thrombocytopenia	2023
Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors. Antiviral chemistry & chemotherapy, 2017, Volume: 25, Issue:3 Topics: Amides; Amodiaquine; Animals; Antiviral Agents; Bunyaviridae; Bunyaviridae Infections; Cell Line; Chlorocebus aethiops; Fever; Humans; Microbial Sensitivity Tests; Pyrazines; Ribavirin; Thrombocytopenia; Virus Replication	2017
[Cytopenias and their correction during antiviral therapy of chronic hepatitis C in patients with genotype 1]. Voprosy virusologii, 2017, Volume: 62, Issue:4 Topics: Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia; Treatment Outcome	2017
Crimean-Congo haemorrhagic fever in a Greek worker returning from Bulgaria, June 2018. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2018, Volume: 23, Issue:35 Topics: Animals; Antiviral Agents; Bulgaria; Greece; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, Crimean; Humans; Male; Ribavirin; Thrombocytopenia; Ticks; Transients and Migrants; Travel; Treatment Outcome	2018
Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2013, Volume: 32, Issue:5 Topics: Adolescent; Adult; Aged; Anemia; Antiviral Agents; Drug Therapy, Combination; Egypt; Female; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferon-alpha; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Polyethylene Glycols; Predictive Value of Tests; Recombinant Proteins; Ribavirin; Thrombocytopenia; Young Adult	2013
Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort. Alimentary pharmacology & therapeutics, 2014, Volume: 39, Issue:1 Topics: Antiviral Agents; Cohort Studies; Comparative Effectiveness Research; Female; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Neutropenia; Oligopeptides; Polyethylene Glycols; Proline; Protease Inhibitors; Ribavirin; Thrombocytopenia; United States; Veterans	2014
Valuable antiviral therapeutic options for the treatment of chronic hepatitis C patients with thrombocytopenia. Journal of viral hepatitis, 2013, Volume: 20, Issue:12 Topics: Aged; Antiviral Agents; Cohort Studies; Female; Hemoglobins; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Platelet Count; Polyethylene Glycols; Pyrophosphatases; Recombinant Proteins; Ribavirin; Thrombocytopenia; Treatment Outcome; Viral Load	2013
Romiplostim for severe thrombocytopenia in the treatment of chronic hepatitis C virus infection: a new option for clinicians? The new microbiologica, 2014, Volume: 37, Issue:1 Topics: Antiviral Agents; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Platelet Count; Receptors, Fc; Recombinant Fusion Proteins; Ribavirin; Thrombocytopenia; Thrombopoietin; Treatment Outcome	2014
Severe thrombocytopenia in a patient with inosine triphosphatase (ITPA)-CC genotype caused by pegylated interferon (IFN)-α-2a with ribavirin therapy: a case report. BMC research notes, 2014, Mar-12, Volume: 7 Topics: Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Glucocorticoids; Hepatitis C, Chronic; Humans; Inosine Triphosphatase; Interferon-alpha; Middle Aged; Platelet Count; Polyethylene Glycols; Prednisolone; Pyrophosphatases; Recombinant Proteins; Ribavirin; Thrombocytopenia; Treatment Outcome	2014
Feasibility of pegylated interferon and ribavirin in hepatitis C-related cirrhosis with neutropenia or thrombocytopenia. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2014, Volume: 46, Issue:7 Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Epistaxis; Esophageal and Gastric Varices; Feasibility Studies; Female; Gastrointestinal Hemorrhage; Gingival Hemorrhage; Hepatitis C, Chronic; Humans; Infections; Interferon-alpha; Leukocyte Count; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Neutrophils; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Thrombocytopenia	2014
Incident severe thrombocytopenia in veterans treated with pegylated interferon plus ribavirin for chronic hepatitis C infection. Pharmacoepidemiology and drug safety, 2014, Volume: 23, Issue:5 Topics: Antiviral Agents; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Multivariate Analysis; Platelet Count; Polyethylene Glycols; Proportional Hazards Models; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Severity of Illness Index; Thrombocytopenia; United States; Veterans	2014
Middle East respiratory syndrome. Intensive care medicine, 2014, Volume: 40, Issue:7 Topics: Acute Kidney Injury; Algorithms; Antiviral Agents; Coronavirus Infections; Critical Care; Critical Illness; Humans; Interferons; L-Lactate Dehydrogenase; Lymphopenia; Protective Clothing; Respiration, Artificial; Ribavirin; Thrombocytopenia	2014
Association between IPTA gene polymorphisms and hematological abnormalities in hepatitis C virus-infected patients receiving combination therapy. Gut and liver, 2015, Volume: 9, Issue:2 Topics: Adult; Aged; Anemia; Antiviral Agents; Cross-Sectional Studies; Drug Therapy, Combination; Female; Hematologic Diseases; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrophosphatases; Retrospective Studies; Ribavirin; Taiwan; Thrombocytopenia	2015
Safety and efficacy of partial splenic embolization in telaprevir-based triple therapy for chronic hepatitis C. Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:2 Topics: Adult; Aged; Antiviral Agents; Combined Modality Therapy; Drug Therapy, Combination; Embolization, Therapeutic; Female; Genotype; Hepatitis C, Chronic; Humans; Hypersplenism; Interferon-alpha; Interferons; Interleukins; Male; Middle Aged; Oligopeptides; Platelet Count; Polyethylene Glycols; Pyrophosphatases; Ribavirin; Thrombocytopenia; Treatment Outcome	2015
[Natural human IFNβ and ribavirin combination therapy]. Nihon rinsho. Japanese journal of clinical medicine, 2015, Volume: 73, Issue:2 Topics: Aged; Depression; Drug Therapy, Combination; Hemophilia A; Hepatitis C, Chronic; Humans; Interferon-beta; Ribavirin; Thrombocytopenia	2015
Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy. Journal of gastroenterology and hepatology, 2015, Volume: 30, Issue:8 Topics: Adult; Age Factors; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Prevalence; Recombinant Proteins; Ribavirin; Sex Factors; Thrombocytopenia; Treatment Outcome	2015
Prognostic effect of response to interferon therapy after laparoscopic splenectomy among patients with marked thrombocytopenia and hepatitis C virus-related cirrhosis. Hepatology international, 2015, Volume: 9, Issue:1 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Disease-Free Survival; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Laparoscopy; Leukocyte Count; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Platelet Count; Polyethylene Glycols; Prognosis; Recombinant Proteins; Ribavirin; RNA, Viral; Splenectomy; Survival Rate; Thrombocytopenia; Viral Load	2015
Antiviral treatment discontinuation among hepatitis C-infected individuals with thrombocytopenia. Journal of viral hepatitis, 2015, Volume: 22, Issue:5 Topics: Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Ribavirin; Thrombocytopenia; Withholding Treatment	2015
Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, Volume: 34, Issue:9 Topics: Adult; Antiviral Agents; Cohort Studies; Coinfection; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Interferon-alpha; Male; Middle Aged; Platelet Count; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Risk; Spain; Thrombocytopenia; Treatment Outcome; Viral Load	2015
EPIDEMIOLOGY, CLINICAL AND LABORATORY FEATURES OF CRIMEAN-CONGO HEMORRHAGIC FEVER IN GEORGIA. Georgian medical news, 2015, Issue:247 Topics: Adolescent; Adult; Aged; Animals; Antiviral Agents; Arachnid Vectors; Aspartate Aminotransferases; Biomarkers; Child; Child, Preschool; Creatine; Diarrhea; Female; Georgia (Republic); Hemorrhage; Hemorrhagic Fever Virus, Crimean-Congo; Hemorrhagic Fever, Crimean; Humans; Male; Middle Aged; Prospective Studies; Prothrombin Time; Ribavirin; Survival Analysis; Thrombocytopenia; Ticks	2015
Sustained viral response and treatment-induced cytopenia correlate with SLCs and KLF12 genotypes in interferon/ribavirin-treated Chinese chronic hepatitis C patients. Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:8 Topics: Adult; Anion Transport Proteins; Antiporters; Antiviral Agents; China; Drug Therapy, Combination; Equilibrative Nucleoside Transporter 1; Female; Genetic Predisposition to Disease; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Kruppel-Like Transcription Factors; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Pharmacogenomic Variants; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Sustained Virologic Response; Thrombocytopenia; Time Factors; Treatment Outcome	2016
Role of ITPA gene polymorphism in ribavirin-induced anemia and thrombocytopenia in Egyptian patients with chronic hepatitis C. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2016, Volume: 35, Issue:1 Topics: Adult; Anemia; Antiviral Agents; Egypt; Female; Genetic Association Studies; Genotyping Techniques; Hepatitis C, Chronic; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Pyrophosphatases; Real-Time Polymerase Chain Reaction; Ribavirin; Thrombocytopenia; Young Adult	2016
KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy. The pharmacogenomics journal, 2017, Volume: 17, Issue:4 Topics: Adult; Antiviral Agents; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Male; Platelet Count; Receptors, KIR; Ribavirin; Thrombocytopenia	2017
Difficult management of triple therapy for chronic hepatitis C in a patient on haemodialysis. Gastroenterologia y hepatologia, 2017, Volume: 40, Issue:5 Topics: Anemia, Hemolytic; Antiviral Agents; Bacteremia; Blood Component Transfusion; Catheter-Related Infections; Drug Therapy, Combination; Glomerulonephritis; Graft Rejection; Hepatitis C, Chronic; Humans; Immunosuppression Therapy; Interferon-alpha; Kidney Failure, Chronic; Kidney Transplantation; Liver Cirrhosis; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Postoperative Complications; Recombinant Proteins; Renal Dialysis; Ribavirin; Staphylococcal Infections; Thrombocytopenia	2017
The Korean journal of internal medicine, 2017, Volume: 32, Issue:4 Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Microbial Sensitivity Tests; Phlebovirus; Ribavirin; Thrombocytopenia; Tick-Borne Diseases; Vero Cells	2017
A Pediatric Case of Severe Fever with Thrombocytopenia Syndrome in Korea. Journal of Korean medical science, 2017, Volume: 32, Issue:4 Topics: Animals; Antiviral Agents; Child; Female; Humans; Myalgia; Phlebotomus Fever; Phlebovirus; Republic of Korea; Ribavirin; Steroids; Thrombocytopenia; Ticks	2017
[Haematologic adverse effects of treatment of chronic viral hepatitis B and C]. Klinicka mikrobiologie a infekcni lekarstvi, 2008, Volume: 14, Issue:2 Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Female; Hemoglobins; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia	2008
[Thrombopoietin-receptor agonists: a revolution in the therapeutic strategies of immune thrombocytopenic purpura?]. La Revue de medecine interne, 2009, Volume: 30, Issue:3 Topics: Administration, Oral; Adult; Antiviral Agents; Benzoates; Carrier Proteins; Controlled Clinical Trials as Topic; Drug Therapy, Combination; Female; Hepatitis C; Humans; Hydrazines; Immunoglobulins, Intravenous; Injections, Subcutaneous; Interferons; Myelodysplastic Syndromes; Placebos; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Ribavirin; Splenectomy; Thrombocytopenia; Thrombopoietin; Time Factors	2009
Role of growth factors and thrombopoietic agents in the treatment of chronic hepatitis C. Current gastroenterology reports, 2009, Volume: 11, Issue:1 Topics: Antiviral Agents; Benzoates; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Hydrazines; Intercellular Signaling Peptides and Proteins; Interferon alpha-2; Interferon-alpha; Platelet Count; Polyethylene Glycols; Pyrazoles; Recombinant Proteins; Ribavirin; Thrombocytopenia; Thrombopoiesis; Treatment Outcome	2009
Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin. Annals of hematology, 2010, Volume: 89, Issue:2 Topics: Adult; Anemia; Antiviral Agents; Female; Genotype; Hematologic Diseases; Hepatitis C, Chronic; Humans; Interferons; Male; Middle Aged; Multivariate Analysis; Neutropenia; Ribavirin; Risk Factors; Thrombocytopenia	2010
Splenectomy and antiviral treatment for thrombocytopenic patients with chronic hepatitis C virus infection. Journal of viral hepatitis, 2010, Volume: 17, Issue:7 Topics: Aged; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Splenectomy; Splenomegaly; Thrombocytopenia; Treatment Outcome; Viral Load	2010
Weight loss, leukopenia and thrombocytopenia associated with sustained virologic response to Hepatitis C treatment. International journal of medical sciences, 2010, Jan-22, Volume: 7, Issue:1 Topics: Antiviral Agents; Drug Combinations; Drug Resistance, Viral; Female; Genotype; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Leukopenia; Male; Middle Aged; Polyethylene Glycols; Prognosis; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Thrombocytopenia; Time Factors; Weight Loss	2010
A case of severe thrombocytopenia in a patient with chronic hepatitis C caused by a single administration of pegylated interferon α 2a subsequent to 48 weeks of pegylated interferon α 2b plus ribavirin therapy. Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:16 Topics: Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Severity of Illness Index; Thrombocytopenia	2010
A laparoscopic splenectomy allows the induction of antiviral therapy for patients with cirrhosis associated with hepatitis C virus. The American surgeon, 2011, Volume: 77, Issue:2 Topics: Aged; Antiviral Agents; Blood Loss, Surgical; Contraindications; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Laparoscopy; Length of Stay; Liver Cirrhosis; Male; Middle Aged; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Splenectomy; Thrombocytopenia	2011
Medical resource utilisation and healthcare costs in patients with chronic hepatitis C viral infection and thrombocytopenia. Journal of medical economics, 2011, Volume: 14, Issue:2 Topics: Antiviral Agents; Blood Transfusion; Disease Progression; Female; Health Care Costs; Health Resources; Hepatitis C, Chronic; Humans; Inpatients; Insurance Claim Review; Interferons; Male; Middle Aged; Outpatients; Platelet Count; Regression Analysis; Retrospective Studies; Ribavirin; Thrombocytopenia; United States	2011
Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infection. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2011, Volume: 9, Issue:7 Topics: Adult; Antiviral Agents; Elasticity Imaging Techniques; Female; Hepatitis C, Chronic; Humans; Incidence; Interferon alpha-2; Interferon-alpha; Interferons; Interleukins; Liver; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Polymorphism, Genetic; Portal Pressure; Predictive Value of Tests; Prognosis; Recombinant Proteins; Ribavirin; Thrombocytopenia; Treatment Outcome	2011
A retrospective cohort study of partial splenic embolization for antiviral therapy in chronic hepatitis C with thrombocytopenia. Journal of gastroenterology, 2011, Volume: 46, Issue:8 Topics: Adult; Aged; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Combined Modality Therapy; Embolization, Therapeutic; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Neoplasms; Male; Medication Adherence; Middle Aged; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Splenic Artery; Thrombocytopenia; Treatment Outcome	2011
Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C. Human molecular genetics, 2011, Sep-01, Volume: 20, Issue:17 Topics: Antiviral Agents; Genome-Wide Association Study; Genotype; Hepatitis C, Chronic; Humans; Interferons; Linkage Disequilibrium; Polymorphism, Single Nucleotide; Pyrophosphatases; Ribavirin; Thrombocytopenia	2011
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients. Journal of hepatology, 2012, Volume: 56, Issue:2 Topics: Adult; Antiviral Agents; Female; Genome-Wide Association Study; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukopenia; Linkage Disequilibrium; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Polymorphism, Single Nucleotide; Pyrophosphatases; Recombinant Proteins; Ribavirin; Thrombocytopenia	2012
Natural leukocyte interferon alpha (Alfaferone) combined with ribavirin in the treatment of patients with HCV-related cirrhosis: our experience. Infection, 2011, Volume: 39, Issue:5 Topics: Adolescent; Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Fibrosis; Hepacivirus; Hepatitis C; Humans; Interferon-alpha; Leukopenia; Male; Middle Aged; Poland; Polymerase Chain Reaction; Ribavirin; Thrombocytopenia; Treatment Outcome; Young Adult	2011
Laparoscopic splenectomy with interferon therapy in 100 hepatitis-C-virus-cirrhotic patients with hypersplenism and thrombocytopenia. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:2 Topics: Adult; Aged; Antiviral Agents; Combined Modality Therapy; Drug Therapy, Combination; Female; Hand-Assisted Laparoscopy; Hepatitis C; Humans; Hypersplenism; Interferon alpha-2; Interferon-alpha; Japan; Laparoscopy; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Splenectomy; Thrombocytopenia; Time Factors; Treatment Outcome	2012
Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. The American journal of gastroenterology, 2011, Volume: 106, Issue:8 Topics: Aged; Alanine Transaminase; Antibodies; Antiviral Agents; Biomarkers; Chronic Disease; Female; Hepatitis E; Hepatitis E virus; Humans; Immunoglobulin A; Immunoglobulin M; Leukemia, Myelomonocytic, Chronic; Ribavirin; Thrombocytopenia; Treatment Outcome; Viral Load	2011
Partial splenic embolization facilitates the adherence to peginterferon in chronic hepatitis C with thrombocytopenia. Internal medicine (Tokyo, Japan), 2011, Volume: 50, Issue:22 Topics: Adult; Aged; Antiviral Agents; Embolization, Therapeutic; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Splenic Artery; Thrombocytopenia; Treatment Outcome	2011
Factors linked to severe thrombocytopenia during antiviral therapy in patients with chronic hepatitis c and pretreatment low platelet counts. BMC gastroenterology, 2012, Jan-18, Volume: 12 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Multivariate Analysis; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Severity of Illness Index; Thrombocytopenia	2012
Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy. Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:7 Topics: Adolescent; Adult; Age Factors; Aged; Anemia; Antiviral Agents; Contraindications; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Neutropenia; Polyethylene Glycols; Practice Guidelines as Topic; Prevalence; Retrospective Studies; Ribavirin; Thrombocytopenia; Young Adult	2012
Successful antiviral therapy for hepatitis C virus-induced cirrhosis after an increase in the platelet count with romiplostim: two case reports. European journal of gastroenterology & hepatology, 2012, Volume: 24, Issue:12 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Middle Aged; Platelet Count; Receptors, Fc; Recombinant Fusion Proteins; Ribavirin; Risk Factors; Severity of Illness Index; Thrombocytopenia; Thrombopoietin; Time Factors; Treatment Outcome	2012
Use of romiplostim allows for hepatitis C therapy in a HIV/HCV coinfected patient. Annals of hematology, 2013, Volume: 92, Issue:7 Topics: Adult; Anti-HIV Agents; Antiviral Agents; Hepatitis C; HIV Infections; Humans; Interferon-alpha; Male; Platelet Count; Polyethylene Glycols; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Recombinant Proteins; Ribavirin; Thrombocytopenia; Thrombopoietin	2013
Role of epoetin alfa in maintaining ribavirin dose. Gastroenterology clinics of North America, 2004, Volume: 33, Issue:1 Suppl Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Epoetin Alfa; Erythropoietin; Hematinics; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Neutropenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia	2004
Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization. European journal of gastroenterology & hepatology, 2005, Volume: 17, Issue:11 Topics: Antiviral Agents; Combined Modality Therapy; Drug Therapy, Combination; Embolization, Therapeutic; Female; Hepatitis C, Chronic; Humans; Hypersplenism; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Thrombocytopenia; Treatment Outcome	2005
The use of partial splenic artery embolization made it possible to administer interferon and ribavirin therapy in a liver transplant patient with fibrosing cholestatic hepatitis C complicated with thrombocytopenia. Transplant international : official journal of the European Society for Organ Transplantation, 2006, Volume: 19, Issue:3 Topics: Antiviral Agents; Cholestasis; Embolization, Therapeutic; Female; Hepatitis C; Humans; Interferons; Liver Transplantation; Middle Aged; Ribavirin; Splenectomy; Splenic Artery; Thrombocytopenia	2006
Late onset autoimmune thrombocytopenia associated with pegylated interferon-alpha-2b plus ribavirin treatment for chronic hepatitis C. Journal of gastroenterology and hepatology, 2006, Volume: 21, Issue:3 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia; Treatment Outcome	2006
Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C. Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2006, Volume: 20, Issue:9 Topics: Adult; Age Factors; Aged; Anemia; Antiviral Agents; Biomarkers; Blood Cell Count; Blood Platelets; Drug Therapy, Combination; Female; Hemoglobins; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Male; Middle Aged; Neutropenia; Neutrophils; Polyethylene Glycols; Quebec; Recombinant Proteins; Ribavirin; Risk Factors; Severity of Illness Index; Thrombocytopenia; Treatment Outcome	2006
Life-threatening thrombocytopenia and nephrotic syndrome due to focal segmental glomerulosclerosis associated with pegylated interferon alpha-2b and ribavirin treatment for hepatitis C. Liver international : official journal of the International Association for the Study of the Liver, 2006, Volume: 26, Issue:10 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Nephrotic Syndrome; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia	2006
Standard interferon-alpha in combination with ribavirin for hepatitis C patients with advanced liver disease and thrombocytopenia. Wiener klinische Wochenschrift, 2006, Volume: 118, Issue:19-20 Topics: Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Thrombocytopenia	2006
Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2008, Volume: 6, Issue:2 Topics: Ethnicity; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Leukopenia; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Thrombocytopenia; Treatment Outcome; Viral Load; Weight Loss	2008
Predictors of severe haematological toxicity secondary to pegylated interferon plus ribavirin treatment in HIV-HCV-coinfected patients. Antiviral therapy, 2007, Volume: 12, Issue:8 Topics: Adult; Anemia; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Fibrosis; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Leukocyte Count; Male; Neutropenia; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Spain; Thrombocytopenia; Zidovudine	2007
From the Centers for Disease Control and Prevention. Update: hantavirus pulmonary syndrome--United States, 1993. JAMA, 1993, Nov-17, Volume: 270, Issue:19 Topics: Bunyaviridae Infections; Clinical Trials as Topic; Fever; Humans; Lung Diseases, Interstitial; Orthohantavirus; Polymerase Chain Reaction; Pulmonary Edema; Respiratory Distress Syndrome; Ribavirin; Thrombocytopenia; United States	1993
Update: hantavirus pulmonary syndrome--United States, 1993. MMWR. Morbidity and mortality weekly report, 1993, Oct-29, Volume: 42, Issue:42 Topics: Adolescent; Adult; Aged; Bunyaviridae Infections; Child; Clinical Trials as Topic; Female; Fever; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Orthohantavirus; Polymerase Chain Reaction; Pulmonary Edema; Respiratory Distress Syndrome; Ribavirin; Thrombocytopenia; United States	1993
Ribavirin therapy for cryoglobulinemia and thrombocytopenia associated with hepatitis C virus infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:6 Topics: Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C; Humans; Middle Aged; Ribavirin; Thrombocytopenia	1997
Sustained response to combination therapy in a patient with chronic hepatitis C and thrombocytopenia secondary to alpha-interferon. Journal of gastroenterology and hepatology, 2000, Volume: 15, Issue:5 Topics: Antiviral Agents; Combined Modality Therapy; Hepatitis C, Chronic; Humans; Immunoglobulin G; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Prednisone; Recombinant Proteins; Ribavirin; Thrombocytopenia	2000
Effect of orally administered ribavirin on experimental feline calicivirus infection in cats. American journal of veterinary research, 1978, Volume: 39, Issue:8 Topics: Administration, Oral; Animals; Caliciviridae; Cat Diseases; Cats; Lung; Ribavirin; Ribonucleosides; Thrombocytopenia; Virus Diseases	1978
Hematologic dysfunction in Lassa fever. Journal of medical virology, 1988, Volume: 26, Issue:2 Topics: Humans; Lassa Fever; Leukocyte Count; Lymphocytes; Platelet Aggregation; Platelet Count; Prospective Studies; Ribavirin; Thrombocytopenia	1988